Literature DB >> 18218728

The thyrotropin receptor hinge region is not simply a scaffold for the leucine-rich domain but contributes to ligand binding and signal transduction.

Yumiko Mizutori1, Chun-Rong Chen, Sandra M McLachlan, Basil Rapoport.   

Abstract

The glycoprotein hormone receptor hinge region connects the leucine-rich and transmembrane domains. The prevalent concept is that the hinge does not play a significant role in ligand binding and signal transduction. Portions of the hinge are redundant and can be deleted by mutagenesis or are absent in certain species. A minimal hinge will be more amenable to future investigation of its structure and function. We, therefore, combined and progressively extended previous deletions (Delta) in the TSH receptor (TSHR) hinge region (residues 277-418). TSHRDelta287-366, Delta287-371, Delta287-376, and Delta287-384 progressively lost their response to TSH stimulation of cAMP generation in intact cells, consistent with a progressive loss of TSH binding. The longest deletion (TSHRDelta287-384), reducing the hinge region from 141 to 43 amino acids, totally lost both functions. Surprisingly, however, with deletions extending from residues 371-384, constitutive (ligand-independent) activity increased severalfold, reversing the suppressive (inverse agonist) effect of the TSHR extracellular domain. TSHR-activating point mutations I486F and I568T in the first and second extracellular loops (especially the former) had reduced activity on a background of TSHRDelta287-371. In summary, our data support the concept that the TSHR hinge contributes significantly to ligand binding affinity and signal transduction. Residues within the hinge, particularly between positions 371-384, appear involved in ectodomain inverse agonist activity. In addition, the hinge is necessary for functionality of activating mutations in the first and second extracellular loops. Rather than being an inert linker between the leucine-rich and transmembrane domains, the TSHR hinge is a signaling-specificity domain.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18218728      PMCID: PMC2366178          DOI: 10.1210/me.2007-0407

Source DB:  PubMed          Journal:  Mol Endocrinol        ISSN: 0888-8809


  41 in total

Review 1.  The thyrotropin receptor and the regulation of thyrocyte function and growth.

Authors:  G Vassart; J E Dumont
Journal:  Endocr Rev       Date:  1992-08       Impact factor: 19.871

2.  Evidence that the thyrotropin receptor ectodomain contains not one, but two, cleavage sites.

Authors:  G D Chazenbalk; K Tanaka; Y Nagayama; A Kakinuma; J C Jaume; S M McLachlan; B Rapoport
Journal:  Endocrinology       Date:  1997-07       Impact factor: 4.736

3.  Follitropin receptors contain cryptic ligand binding sites.

Authors:  Win Lin; Michael P Bernard; Donghui Cao; Rebecca V Myers; John E Kerrigan; William R Moyle
Journal:  Mol Cell Endocrinol       Date:  2006-10-23       Impact factor: 4.102

4.  Somatic mutations in the thyrotropin receptor gene cause hyperfunctioning thyroid adenomas.

Authors:  J Parma; L Duprez; J Van Sande; P Cochaux; C Gervy; J Mockel; J Dumont; G Vassart
Journal:  Nature       Date:  1993-10-14       Impact factor: 49.962

5.  Cloning and functional expression of the luteinizing hormone receptor complementary deoxyribonucleic acid from the marmoset monkey testis: absence of sequences encoding exon 10 in other species.

Authors:  F P Zhang; A S Rannikko; P R Manna; H M Fraser; I T Huhtaniemi
Journal:  Endocrinology       Date:  1997-06       Impact factor: 4.736

6.  Further characterization of a high affinity thyrotropin binding site on the rat thyrotropin receptor which is an epitope for blocking antibodies from idiopathic myxedema patients but not thyroid stimulating antibodies from Graves' patients.

Authors:  S Kosugi; T Ban; T Akamizu; L D Kohn
Journal:  Biochem Biophys Res Commun       Date:  1991-10-31       Impact factor: 3.575

7.  Critical relationship between autoantibody recognition and thyrotropin receptor maturation as reflected in the acquisition of complex carbohydrate.

Authors:  B Rapoport; S M McLachlan; A Kakinuma; G D Chazenbalk
Journal:  J Clin Endocrinol Metab       Date:  1996-07       Impact factor: 5.958

8.  Role of cysteine residues in the extracellular domain and exoplasmic loops of the transmembrane domain of the TSH receptor: effect of mutation to serine on TSH receptor activity and response to thyroid stimulating autoantibodies.

Authors:  S Kosugi; T Ban; T Akamizu; L D Kohn
Journal:  Biochem Biophys Res Commun       Date:  1992-12-30       Impact factor: 3.575

9.  Somatic mutations causing constitutive activity of the thyrotropin receptor are the major cause of hyperfunctioning thyroid adenomas: identification of additional mutations activating both the cyclic adenosine 3',5'-monophosphate and inositol phosphate-Ca2+ cascades.

Authors:  J Parma; J Van Sande; S Swillens; M Tonacchera; J Dumont; G Vassart
Journal:  Mol Endocrinol       Date:  1995-06

10.  Thyrotropin-luteinizing hormone/chorionic gonadotropin receptor extracellular domain chimeras as probes for thyrotropin receptor function.

Authors:  Y Nagayama; H L Wadsworth; G D Chazenbalk; D Russo; P Seto; B Rapoport
Journal:  Proc Natl Acad Sci U S A       Date:  1991-02-01       Impact factor: 11.205

View more
  35 in total

1.  The Activation Mechanism of Glycoprotein Hormone Receptors with Implications in the Cause and Therapy of Endocrine Diseases.

Authors:  Antje Brüser; Angela Schulz; Sven Rothemund; Albert Ricken; Davide Calebiro; Gunnar Kleinau; Torsten Schöneberg
Journal:  J Biol Chem       Date:  2015-11-18       Impact factor: 5.157

2.  Structure of a Thyrotropin Receptor Monoclonal Antibody Variable Region Provides Insight into Potential Mechanisms for its Inverse Agonist Activity.

Authors:  Chun-Rong Chen; Sandra M McLachlan; Paul A Hubbard; Randall McNally; Ramachandran Murali; Basil Rapoport
Journal:  Thyroid       Date:  2018-06-29       Impact factor: 6.568

3.  The antibodies against the computationally designed mimic of the glycoprotein hormone receptor transmembrane domain provide insights into receptor activation and suppress the constitutively activated receptor mutants.

Authors:  Ritankar Majumdar; Reema Railkar; Rajan R Dighe
Journal:  J Biol Chem       Date:  2012-08-17       Impact factor: 5.157

Review 4.  Domain coupling in GPCRs: the engine for induced conformational changes.

Authors:  Hamiyet Unal; Sadashiva S Karnik
Journal:  Trends Pharmacol Sci       Date:  2011-10-29       Impact factor: 14.819

Review 5.  Targeting the thyroid-stimulating hormone receptor with small molecule ligands and antibodies.

Authors:  Terry F Davies; Rauf Latif
Journal:  Expert Opin Ther Targets       Date:  2015-03-13       Impact factor: 6.902

6.  A monoclonal antibody with thyrotropin (TSH) receptor inverse agonist and TSH antagonist activities binds to the receptor hinge region as well as to the leucine-rich domain.

Authors:  Chun-Rong Chen; Sandra M McLachlan; Basil Rapoport
Journal:  Endocrinology       Date:  2009-03-19       Impact factor: 4.736

7.  Identification of key amino acid residues in a thyrotropin receptor monoclonal antibody epitope provides insight into its inverse agonist and antagonist properties.

Authors:  Chun-Rong Chen; Sandra M McLachlan; Basil Rapoport
Journal:  Endocrinology       Date:  2008-04-03       Impact factor: 4.736

Review 8.  TSH Receptor Cleavage Into Subunits and Shedding of the A-Subunit; A Molecular and Clinical Perspective.

Authors:  Basil Rapoport; Sandra M McLachlan
Journal:  Endocr Rev       Date:  2016-02       Impact factor: 19.871

9.  The superagonistic activity of bovine thyroid-stimulating hormone (TSH) and the human TR1401 TSH analog is determined by specific amino acids in the hinge region of the human TSH receptor.

Authors:  Sandra Mueller; Gunnar Kleinau; Mariusz W Szkudlinski; Holger Jaeschke; Gerd Krause; Ralf Paschke
Journal:  J Biol Chem       Date:  2009-04-22       Impact factor: 5.157

10.  The thyrotropin receptor hinge region as a surrogate ligand: identification of loci contributing to the coupling of thyrotropin binding and receptor activation.

Authors:  Chun-Rong Chen; Larry M Salazar; Sandra M McLachlan; Basil Rapoport
Journal:  Endocrinology       Date:  2012-10       Impact factor: 4.736

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.